Methods of modifying genes in eukaryotic cells
AssigneeRegeneron Pharmaceuticals, Inc.
InventorsAris N. Economides, David M. Valenzuela, Samuel Davis, George Yancopoulos
Life of this patent
Estimating the term…
Loading patent…
AssigneeRegeneron Pharmaceuticals, Inc.
InventorsAris N. Economides, David M. Valenzuela, Samuel Davis, George Yancopoulos
Estimating the term…
Methods of creating mutations in genomic exons by inserting introns into the genomic exons via homologous recombination. Also, methods are provided for introducing modifications into genomic exons by inserting introns into the genomic exons via homologous recombination such that a mature mRNA transcript produced from a genomic region of the genome comprising the genomic exon does not contain the modification are provided. The methods provide for a rapid method for introducing mutations and/or modifications of any type into a mammalian cell genome.
A method creating a mutation in a genomic exon in the genome of a mammalian embryonic stem (ES) cell, comprising:
A method introducing a modification into a genomic exon in the genome of a eukaryotic cell, comprising introducing an intron into a genomic exon by homologous recombination such that a mature mRNA transcript produced from a genomic region of the genome comprising the genomic exon does not contain the modification, wherein the method optionally comprises at least one of:
A method introducing a modification into a genomic exon in the genome of an embryonic stem (ES) cell, comprising:
Dependencies are inferred from the claim text.